#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Samuel Lam Email
SVP Science & Research . Immunophotonics
How to contact Samuel Lam
Join and see Samuel's contact info for free!Current Roles
Employees:
18Revenue:
$1.8MAbout
Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid tumor cancers. IP-001 has unique physio-chemical and immunological properties that allows it to ignite a systemically active cancer immunotherapy from a routine tumor ablation; a minimal invasive intervention that destroys tumors and in doing so liberates tumor antigens. IP-001 enhances interactions of tumor antigens with the immune system, improves the motility of tumor infiltrating T cells, promotes their surveillance of tumor tissue and can generate long-term protective immunity.Immunophotonics Address
4340 Duncan Ave.St. Louis, MO